BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30528494)

  • 1. Subcutaneous spacer injection to reduce skin toxicity in breast brachytherapy: A pilot study on mastectomy specimens.
    Struik GM; Pignol JP; Kolkman-Deurloo IK; Godart J; Verduijn GM; Koppert LB; Birnie E; Ghandi A; Klem TM
    Brachytherapy; 2019; 18(2):204-210. PubMed ID: 30528494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol.
    Struik GM; Godart J; Verduijn GM; Kolkman-Deurloo IK; de Vries KC; de Boer R; Koppert LB; Birnie E; Ghandi A; Klem TM; Pignol JP
    Trials; 2018 Dec; 19(1):689. PubMed ID: 30558672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients.
    Prada PJ; Gonzalez H; Menéndez C; Llaneza A; Fernández J; Santamarta E; Ricarte PP
    Brachytherapy; 2009; 8(2):210-217. PubMed ID: 19213607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin dose in breast brachytherapy: Defining a robust metric.
    Hilts M; Halperin H; Morton D; Batchelar D; Bachand F; Chowdhury R; Crook J
    Brachytherapy; 2015; 14(6):970-8. PubMed ID: 26412617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reliable skin toxicity predictor in permanent breast seed implant brachytherapy.
    Anjomani Z; Hilts M; Batchelar D; Crook J
    Brachytherapy; 2020; 19(5):685-693. PubMed ID: 32739213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiochromic film in vivo dosimetry predicts early the risk of acute skin toxicity for brachytherapy partial breast irradiation.
    Struik GM; Godart J; Klem TM; Monajemi TT; Robar J; Pignol JP
    Phys Med Biol; 2020 Apr; 65(8):085001. PubMed ID: 32126542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy.
    Beydoun N; Bucci JA; Chin YS; Malouf D; Enari E; Painter SD
    Brachytherapy; 2013; 12(4):368-74. PubMed ID: 23453682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
    Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated partial-breast irradiation with interstitial implants: the clinical relevance of the calculation of skin doses.
    Ott OJ; Lotter M; Sauer R; Strnad V
    Strahlenther Onkol; 2007 Aug; 183(8):426-31. PubMed ID: 17680222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique.
    Vaggers S; Rai BP; Chedgy ECP; de la Taille A; Somani BK
    World J Urol; 2021 Jun; 39(6):1769-1780. PubMed ID: 32840655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Brachytherapy Society consensus report for accelerated partial breast irradiation using interstitial multicatheter brachytherapy.
    Hepel JT; Arthur D; Shaitelman S; Polgár C; Todor D; Zoberi I; Kamrava M; Major T; Yashar C; Wazer DE
    Brachytherapy; 2017; 16(5):919-928. PubMed ID: 28676428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy.
    Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Pow-Sang JM; Spiess PE; Sexton WJ; Poch MA; Biagioli MC
    Radiother Oncol; 2014 Apr; 111(1):126-31. PubMed ID: 24746567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
    Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: A systematic review.
    Afkhami Ardekani M; Ghaffari H
    Brachytherapy; 2020; 19(1):13-23. PubMed ID: 31542390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicatheter interstitial brachytherapy versus intensity modulated external beam therapy for accelerated partial breast irradiation: A comparative treatment planning study with respect to dosimetry of organs at risk.
    Major T; Stelczer G; Pesznyák C; Mészáros N; Polgár C
    Radiother Oncol; 2017 Jan; 122(1):17-23. PubMed ID: 27544819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.